Rehabilitation program for children recovering from cancer treatment
Multidisciplinary Rehabilitation of Children and Adolescents After Acute Cancer Treatment
This study is testing a new rehabilitation program to help children and teens who have finished cancer treatment improve their strength, energy, and overall quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 8 Years to 21 Years |
| Sex | All |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent) |
| Trial ID | NCT05154305 on ClinicalTrials.gov |
What this trial studies
This study aims to develop a multidisciplinary rehabilitation program for children and adolescents who have completed acute cancer treatment. It addresses the long-term side effects experienced by survivors, such as reduced muscle strength, endurance, and exercise tolerance, as well as fatigue and changes in body composition. The program will focus on improving physical functioning and daily living activities through targeted interventions. The study will evaluate the effectiveness of this rehabilitation approach in enhancing the quality of life for young cancer survivors.
Who should consider this trial
Good fit: Ideal candidates are children aged between 6 months and 8 years who have completed acute cancer treatment and are off medical therapy.
Not a fit: Patients who are unable to participate for three consecutive weeks or have relapsed may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the physical health and quality of life for children recovering from cancer.
How similar studies have performed: Other studies have shown promising results with multidisciplinary rehabilitation approaches for cancer survivors, indicating potential success for this program.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * between 6 months and 8 years post acute cancer treatment * off medical treatment * all possible cancer diagnosis, except for brain tumors and sarcomas Exclusion Criteria: * not able to participate for 3 consecutive weeks * not able to perform a maximal cardiopulmonary exercise test * unwilling to cooperate * relapse
Where this trial is running
Ghent
- Ghent University Hospital — Ghent, Belgium (Recruiting)
Study contacts
- Principal investigator: Catharina Dhooghe, MD, PhD — University Hospital, Ghent
- Study coordinator: Catharina Dhooge, MD, PhD
- Email: CATHARINA.DHOOGE@UZGENT.BE
- Phone: 00329/3322452
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.